SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter K. Kimani, Susan Todd, Nigel Stallard, A comparison of methods for constructing confidence intervals after phase II/III clinical trials, Biometrical Journal, 2014, 56, 1
  2. 2
    Michael D. Pickard, Mark Chang, A Flexible Method Using a Parametric Bootstrap for Reducing Bias in Adaptive Designs With Treatment Selection, Statistics in Biopharmaceutical Research, 2014, 6, 2, 163

    CrossRef

  3. 3
    Werner Brannath, Sylvia Schmidt, A new class of powerful and informative simultaneous confidence intervals, Statistics in Medicine, 2014, 33, 19
  4. 4
    Nigel Stallard, Thomas Hamborg, Nicholas Parsons, Tim Friede, Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection, Journal of Biopharmaceutical Statistics, 2014, 24, 1, 168

    CrossRef

  5. 5
    Jack Bowden, Ekkehard Glimm, Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials, Biometrical Journal, 2014, 56, 2
  6. 6
    Jack Bowden, Werner Brannath, Ekkehard Glimm, Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach, Statistics in Medicine, 2014, 33, 3
  7. 7
    Peter K. Kimani, Susan Todd, Nigel Stallard, Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility, Statistics in Medicine, 2013, 32, 17
  8. 8
    James M. S. Wason, Reducing the average number of patients needed in a phase II trial through novel design, Clinical Research and Regulatory Affairs, 2013, 30, 4, 47

    CrossRef